Last update 08 May 2025

Instituto de Medicina Regenerativa

Overview

Tags

Neoplasms
Therapeutic vaccine
Personalized antigen vaccine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Neoplasms1
Top 5 Drug TypeCount
Personalized antigen vaccine1
Therapeutic vaccine1

Related

1
Drugs associated with Instituto de Medicina Regenerativa
Neoantigen Peptide Vaccine(Instituto de Medicina Regenerativa)
Target-
Mechanism
Immunostimulants
Active Org.
Instituto de Medicina Regenerativa
Originator Org.
Instituto de Medicina Regenerativa
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhaseEarly Phase 1
First Approval Ctry. / Loc.-
First Approval Date-
11
Clinical Trials associated with Instituto de Medicina Regenerativa
NCT05475106
/ RecruitingEarly Phase 1
Pilot Study of Personalized Neoantigen Peptide Vaccines and Leukine for the Treatment of Neoplasms
NCT04509167
/ CompletedEarly Phase 1
Pilot Study of Personalized Neoantigen Peptide Vaccines for the Treatment of Neoplasms
NCT04456361
/ Active, not recruitingEarly Phase 1
A Study of Mesenchymal Stem Cells as a Treatment in Patients With Acute Respiratory Distress Syndrome Caused by COVID-19
100 Clinical Results associated with Instituto de Medicina Regenerativa
Login to view more data
0 Patents (Medical) associated with Instituto de Medicina Regenerativa
Login to view more data
3
Literatures (Medical) associated with Instituto de Medicina Regenerativa
Revista Peruana de Medicina Experimental y Salud Pública
Organoides: fundamentos, presente y futuro
Revista Peruana de Medicina Experimental y Salud Pública
Procedimiento para el cultivo e identificación de células madre obtenidas de lipoaspirado humano con fines de investigación
Revista Peruana de Medicina Experimental y Salud Pública
Actividad citotóxica de la fracción clorofórmica de Piper aduncum y su efecto en el ciclo celular en líneas celulares de cáncer gástrico
100 Deals associated with Instituto de Medicina Regenerativa
Login to view more data
100 Translational Medicine associated with Instituto de Medicina Regenerativa
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 13 Jul 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Neoantigen Peptide Vaccine(Instituto de Medicina Regenerativa)
Neoplasms
More
Phase 1 Clinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free